Literature DB >> 6251720

Relationship of SV40 T-antigen expression in vitro to disorders of bone marrow function.

A S Lubiniecki, W A Blattner, H Dosik, S McIntosh, W Wertelecki.   

Abstract

Skin fibroblasts from patients with a variety of hematologic disorders were infected with SV40 virus in vitro in attempts to discover the reason for increased susceptibility of Fanconi anemia cells to this transforming virus. The proportion of skin fibroblasts expressing SV40 T-antigen by immunofluorescent methods was elevated in 12 patients with Fanconi anemia and in seven of nine obligate heterozygous relatives. Elevated expression was also observed in three patients with other hematological disorders at high risk of acute non-lymphocytic leukemia, but was not apparent in seven sporadic aplastic anemia patients or four of their relatives. T-antigen expression was elevated in about one-half of patients with thrombocytopenia-absent radius syndrome and related conditions, with familial aplastic anemia, and in their normal relatives. In the conditions under study, elevated T-antigen expression seemed clearly correlated with predisposition to leukemia, which may be genetically determined, but it was not associated with cytogenetic or anemic manifestations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251720     DOI: 10.1002/ajh.2830080407

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (family G of Warthin).

Authors:  A S Lubiniecki; H T Lynch; W A Blattner; H Guirgis
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Reduced uptake and incorporation of 3H-thymidine in Fanconi anemia fibroblasts.

Authors:  M Shoyab; M Gunnell; A S Lubiniecki
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

3.  Fanconi anemia patients are more susceptible to infection with tumor virus SV40.

Authors:  Manola Comar; Daniela De Rocco; Enrico Cappelli; Nunzia Zanotta; Roberta Bottega; Johanna Svahn; Piero Farruggia; Aldo Misuraca; Fabio Corsolini; Carlo Dufour; Anna Savoia
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.